These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1223 related items for PubMed ID: 17274922

  • 1. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].
    Tuxen MK, Nielsen DL, Lindberg H, Kamby C.
    Ugeskr Laeger; 2007 Jan 22; 169(4):297-9. PubMed ID: 17274922
    [Abstract] [Full Text] [Related]

  • 2. [Neoadjuvant antihormonal treatment of women with breast cancer].
    Tuxen MK, Kamby C, Nielsen DL.
    Ugeskr Laeger; 2007 Sep 10; 169(37):3077-81. PubMed ID: 17877952
    [Abstract] [Full Text] [Related]

  • 3. Advances in adjuvant hormonal therapy for postmenopausal women.
    Strasser-Weippl K, Goss PE.
    J Clin Oncol; 2005 Mar 10; 23(8):1751-9. PubMed ID: 15755983
    [No Abstract] [Full Text] [Related]

  • 4. Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.
    Punglia RS, Kuntz KM, Winer EP, Weeks JC, Burstein HJ.
    J Clin Oncol; 2005 Aug 01; 23(22):5178-87. PubMed ID: 15998905
    [Abstract] [Full Text] [Related]

  • 5. Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.
    Litsas G.
    Oncol Nurs Forum; 2008 Jul 01; 35(4):714-21. PubMed ID: 18591176
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant therapy with aromatase inhibitors in postmenopausal, estrogen receptor- positive breast cancer patients: upfront or sequential?
    Dediu M, Median D, Alexandru A, Vremes G, Gal C, Gongu M.
    J BUON; 2009 Jul 01; 14(3):375-9. PubMed ID: 19810126
    [Abstract] [Full Text] [Related]

  • 7. The use of third-generation aromatase inhibitors and tamoxifen in the adjuvant treatment of postmenopausal patients with hormone-dependent breast cancer: evidence based review.
    Poole R, Paridaens R.
    Curr Opin Oncol; 2007 Nov 01; 19(6):564-72. PubMed ID: 17906453
    [Abstract] [Full Text] [Related]

  • 8. Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: evidence and ongoing controversy.
    Wheler J, Johnson M, Seidman A.
    Semin Oncol; 2006 Dec 01; 33(6):672-80. PubMed ID: 17145347
    [Abstract] [Full Text] [Related]

  • 9. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS, Keshaviah A, Thürlimann B, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Colleoni M, Láng I, Del Mastro L, Smith I, Chirgwin J, Nogaret JM, Pienkowski T, Wardley A, Jakobsen EH, Price KN, Goldhirsch A.
    J Clin Oncol; 2007 Feb 10; 25(5):486-92. PubMed ID: 17200148
    [Abstract] [Full Text] [Related]

  • 10. Aromatase inhibitors--extending the benefits of adjuvant therapy beyond tamoxifen.
    Smith IE.
    Breast; 2004 Dec 10; 13 Suppl 1():S3-9. PubMed ID: 15585377
    [Abstract] [Full Text] [Related]

  • 11. Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.
    Carpenter R.
    Eur J Surg Oncol; 2008 Jul 10; 34(7):746-55. PubMed ID: 18296017
    [Abstract] [Full Text] [Related]

  • 12. Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer.
    Dixon JM.
    Expert Rev Anticancer Ther; 2008 Mar 10; 8(3):453-63. PubMed ID: 18366292
    [Abstract] [Full Text] [Related]

  • 13. Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women.
    Mouridsen HT.
    Curr Med Res Opin; 2006 Aug 10; 22(8):1609-21. PubMed ID: 16870085
    [Abstract] [Full Text] [Related]

  • 14. [Adjuvant treatment of breast cancer. Endocrine therapy].
    Mouridsen HT, Andersen J.
    Ugeskr Laeger; 2007 Sep 10; 169(37):3072-6. PubMed ID: 17877951
    [Abstract] [Full Text] [Related]

  • 15. [Future endocrine therapy of breast cancer].
    Ejlertsen B.
    Ugeskr Laeger; 2007 Jan 22; 169(4):296. PubMed ID: 17274921
    [No Abstract] [Full Text] [Related]

  • 16. Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer.
    Koeberle D, Thuerlimann B.
    Expert Rev Anticancer Ther; 2006 Jan 22; 6(1):5-10. PubMed ID: 16375638
    [Abstract] [Full Text] [Related]

  • 17. Endocrine therapy for early breast cancer.
    Hussain SA, Williams S, Stevens A, Rea DW.
    Expert Rev Anticancer Ther; 2004 Oct 22; 4(5):877-88. PubMed ID: 15485321
    [Abstract] [Full Text] [Related]

  • 18. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.
    Winer EP, Hudis C, Burstein HJ, Wolff AC, Pritchard KI, Ingle JN, Chlebowski RT, Gelber R, Edge SB, Gralow J, Cobleigh MA, Mamounas EP, Goldstein LJ, Whelan TJ, Powles TJ, Bryant J, Perkins C, Perotti J, Braun S, Langer AS, Browman GP, Somerfield MR.
    J Clin Oncol; 2005 Jan 20; 23(3):619-29. PubMed ID: 15545664
    [Abstract] [Full Text] [Related]

  • 19. The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.
    Monnier AM.
    Expert Rev Anticancer Ther; 2007 May 20; 7(5):627-34. PubMed ID: 17492927
    [Abstract] [Full Text] [Related]

  • 20. [New developments in the hormonal treatment of breast cancer in postmenopausal women].
    Trunet P, Marty M.
    Bull Cancer; 1999 Oct 20; 86(10):815-20. PubMed ID: 10572232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.